AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MPH Health Care

M&A Activity Mar 31, 2015

5425_rns_2015-03-31_c34ded2b-4853-4377-a0eb-f57474fc8ed1.html

M&A Activity

Open in Viewer

Opens in native device viewer

News Details

Corporate | 31 March 2015 15:14

MPH Mittelständische Pharma Holding AG: purchase of the majority of the equity of CR Capital Real Estate

MPH Mittelständische Pharma Holding AG / Key word(s): Investment

2015-03-31 / 15:14


MPH Mittelständische Pharma Holding AG:

Announcement of the purchase of the majority of the equity of the company CR Capital Real Estate, Berlin.

The company MPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0L1H32), announces the purchase of the majority of the equity of the company CR Capital Real Estate AG, Berlin (ISIN: DE000A0WMQ53).

Already in 2014 we used the attractive pricing of the share, according to our assessment, for an acquisition above the level of 25%. The value and price of the investment developed very positive and motivated us to further increase the holding. MPH owns now more than 50% of the shares. We see further potential for CR Capital Real Estate AG, especially in the segment of healthcare properties, which provide attractive value development with independence from economic cycles.

About MPH Mittelständische Pharma Holding AG:

The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on the growth markets Pharma and Healthcare. The pharmaceutical sector makes a contribution towards cutting costs in the healthcare system with medicines manufactured on the basis of patent-free and patent-protected active substances for the therapy of chronic diseases. The field of healthcare offers healthcare preparations, individual patient therapies, aesthetic surgeries and other medical treatments.

Key figures for the share of MPH Mittelständische Pharma Holding AG:

Subscribed capital: EUR 42,813,842

Listed shares: ordinary shares

ISIN: DE000A0L1H32

WKN: A0L1H3

Stock symbol: 93M

Contact: Linda Reichelt

MPH Mittelständische Pharma Holding AG

Fasanenstraße 77

D-10623 Berlin

Phone:+49 (0) 30 897308660 Fax:+49 (0) 30 897308669

E-Mail: [email protected] Web: www.mph-ag.de


2015-03-31 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: MPH Mittelständische Pharma Holding AG
Fasanenstraße 77
10623 Berlin
Germany
Phone: 030 / 897 308 660
Fax: 030 / 897 308 669
E-mail: [email protected]
Internet: www.mph-ag.de
ISIN: DE000A0L1H32
WKN: A0L1H3
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart; Open Market (Entry Standard) in Frankfurt
End of News DGAP News-Service
- - -
340087  2015-03-31

Talk to a Data Expert

Have a question? We'll get back to you promptly.